Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Red islands: A novel trichoscopic sign in fibrosing alopecia in a pattern distribution.

Journal of the American Academy of Dermatology·2025
Same author

Comment on a Single-Center Retrospective Cohort Study to Describe an Underrecognized Pattern of Alopecia: Macular Alopecia or Alopecia Parvimaculata?

Pediatric dermatology·2025
Same author

Secondary Cutis Verticis Gyrata Induced by Long-Term Use of High-Dose Topical Minoxidil.

Skin appendage disorders·2025
Same author

Comment on 'Differential diagnosis of red scalp: the importance of trichoscopy'.

Clinical and experimental dermatology·2024
Same author

A narrative review of fixed combination calcipotriol/betamethasone aerosol foam (Enstilar<sup>®</sup>) in the management of psoriasis with scalp involvement.

Drugs in context·2024
Same author

Trichoscopic pearl: dynamic trichoscopy sequence of scalp psoriasis before and after the development of Auspitz's sign.

Archives of dermatological research·2023

Related Experiment Video

Updated: Jun 7, 2026

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
06:41

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

Published on: March 9, 2015

Chemotherapy-induced alopecia.

Ralph M Trüeb1

  • 1Center for Dermatology and Hair Diseases, Wallisellen, Zurich, Switzerland.

Current Opinion in Supportive and Palliative Care
|November 4, 2010
PubMed
Summary
This summary is machine-generated.

Chemotherapy-induced hair loss causes significant distress, with no approved treatments currently available. While scalp cooling and supportive care help manage hair loss, research into new pharmacological agents is ongoing.

More Related Videos

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

Related Experiment Videos

Last Updated: Jun 7, 2026

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
06:41

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

Published on: March 9, 2015

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

Area of Science:

  • Dermatology
  • Oncology
  • Pharmacology

Background:

  • Chemotherapy-induced hair loss is a distressing side effect for many cancer patients.
  • It significantly impacts quality of life, with some patients considering declining treatment due to fear of hair loss.

Purpose of the Study:

  • To review current understanding and evaluated agents for managing chemotherapy-induced hair loss.
  • To explore potential future pharmacological interventions.

Main Methods:

  • Review of existing literature on chemotherapy-induced hair loss management.
  • Evaluation of agents like topical minoxidil and scalp cooling.
  • Exploration of experimental approaches including antioxidants, cytokines, growth factors, and apoptosis inhibitors.

Main Results:

  • Topical minoxidil may reduce severity or duration but does not prevent hair loss.
  • Scalp cooling is a major approach, but data quality is often poor.
  • Nutritional status may influence chemotherapy toxicity, suggesting nutritional support could be beneficial.

Conclusions:

  • Currently, no pharmacologic treatments are approved for chemotherapy-induced hair loss.
  • Incidence and severity vary based on the chemotherapy protocol.
  • Hair loss is typically reversible, with hair/scalp care and wigs as effective coping strategies.